Rosen & Barkin's 5-Minute Emergency Medicine Consult (272 page)

Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
8.17Mb size Format: txt, pdf, ePub
DESCRIPTION
  • Generalized term for benign breast changes that are poorly defined
  • No longer considered a pathologic disease process as they are found in the majority of healthy women
  • Most common of all benign breast conditions
  • Changes include:
    • Benign cysts
    • Breast pain (mastalgia or mastodynia), which may or may not be cyclic
    • Diffuse and focal nodularity
    • Palpable fibroadenomas
    • Nipple discharge—may be green or brownish, though usually nonbloody
  • Spontaneous, persistent discharge warrants further evaluation
  • Occurs in ∼60% of women
  • Symptoms of pain and tenderness become progressively worse until menopause
  • Pain is often most prominent during the premenstrual phase and improves with the onset of menses
    • Breast pain alone is a rare symptom of cancer and accounts for only 0.2–2% of cases
  • Synonyms: Adenosis, benign breast disease, cystic mastitis, cystic disease of the breast, fibroadenosis, fibrocystic disease, mammary dysplasia.
ETIOLOGY
  • Mechanism of development not well understood
  • Likely an enhanced or exaggerated reaction of breast tissue to cyclic levels of female reproductive hormones:
    • May be caused by imbalance of the estrogen to progesterone ratio
    • May occur secondary to increased daily prolactin production
  • Most common in women 30–50 yr old
  • Pain is most likely caused by rapid expansion of simple cysts
  • Symptoms may continue into menopause secondary to hormone replacement therapy
  • Incidence is decreased in women taking oral contraceptives
  • Risk factors include:
    • Family history of fibrocystic changes
    • Oral contraceptives
    • Hormone replacement therapy
    • Increasing age
    • Diet (high fat intake; caffeine/methylxanthines)
DIAGNOSIS
SIGNS AND SYMPTOMS
History
  • Mastalgia and tenderness:
    • Persistent or intermittent
    • Often occurs during premenstrual phase of normal menstrual cycle
    • Usually bilateral
    • Pain may radiate to shoulders and upper arms
  • Lumpiness, nodularity:
    • May be localized or generalized
  • Increased engorgement and breast density:
    • Breasts described as being dull and heavy
    • Caused by fluctuations in the size of the cystic areas
  • Spontaneous or expressible nipple discharge
  • Abnormal nipple sensations, including pruritis
  • Family history of cysts is common
Physical-Exam
  • Palpate the 4 breast quadrants while patient is sitting and then while lying down
  • Note any changes from normal, including overlying erythema and warmth that may suggest an alternative diagnosis
  • Examine for regional nodes (axillary, clavicular, etc.)
  • Fibrocystic changes feel doughy with vague nodularity
  • Nodules are typically discrete and mobile
  • Usually more marked in the superior and lateral quadrants
  • Small groups of cysts often described as palpating a “plate full of peas”
  • Large cysts have consistency of a balloon filled with water
  • Breast exam is most sensitive 7–9 days after 1st day of menses when the breasts are least congested
DIAGNOSIS TESTS & NTERPRETATION
Lab
  • A detailed lab evaluation is usually not necessary in the emergency department
  • Prolactin and thyroid-stimulating hormone may be helpful if galactorrhea is present
Imaging
  • Ultrasound if <30 yr old
  • Mammography if >30 yr old
  • Ultrasound:
    • Can differentiate cystic from solid masses
    • Benign cysts:
      • Typically demonstrate a uniform outer margin without asymmetry or irregular thickness of the cyst wall
      • Have no central echoes
      • Posterior wall enhancement is normal
    • Can assist in aspiration of deep and nonpalpable cysts
    • Also used to conservatively follow cyst size
    • Performed at a specialized breast center with trained techs and interpreting radiologists
  • Mammography:
    • Benign changes may falsely appear malignant
    • Difficult to interpret in women <30 yr old due to breast tissue density
    • Should be performed either before aspiration or 7–10 days afterward to avoid artifact
Diagnostic Procedures/Surgery
  • Fine needle aspiration:
    • Usually performed by a specialist
    • May be performed therapeutically for symptomatic or large masses
    • Allows differentiation between cystic and solid masses
    • Obtain cytology studies to evaluate for malignancy
  • Excisional biopsy:
    • Performed by surgeon
    • Indicated for solid lumps that are not proven benign
DIFFERENTIAL DIAGNOSIS
  • Benign breast masses:
    • Breast abscess
    • Duct ectasia
    • Mastitis
    • Simple fibroadenomas
    • Solitary papillomas
  • Malignant breast masses:
    • Atypical hyperplasia
    • Complex fibroadenomas
    • Diffuse papillomatosis
    • Ductal hyperplasia without atypia
    • Sclerosing adenosis
TREATMENT
ED TREATMENT/PROCEDURES
  • Majority of women will not require any medical treatment
  • Conservative therapy:
    • Support bra:
      • Reduces tension on supporting ligaments of the breast
      • May reduce inflammatory response and edema
    • Low dose diuretic for 2–3 days before onset of menses
    • NSAIDs
  • Dietary changes are somewhat controversial:
    • Restricting dietary fat (to 25% of total calories) and eliminating caffeine
    • Increasing vitamin E and vitamin B
      6
    • Herbal preparations such as primrose oil
  • Hormonal therapy:
    • Should be initiated by PCP to enable follow-up during course of treatment
    • Oral contraceptives:
      • May decrease symptoms, particularly after 1 yr of use
    • Danazol (synthetic androgen) and Tamoxifen (partial estrogen antagonist):
      • Shown to be equally effective for treatment of severe cyclical mastalgia
      • Use may be limited by side effects (acne, hirsutism, weight gain, teratogenicity)
    • Bromocriptine (inhibits prolactin production):
      • Use also limited by side effects (headache, dizziness, nausea, constipation, weakness)
  • Surgical intervention:
    • If a persistent nodule exists, excision is recommended regardless of findings on diagnostic imaging
    • If a large cyst recurs after aspiration on 2 occasions, it should be excised and sent for pathology
MEDICATION
  • Bromocriptine: 2.5–5 mg/d BID
  • Danazol: 100–400 mg/d BID for 6 mo
  • Tamoxifen: 10–20 mg/d
  • Oral contraceptive pills (vary)
FOLLOW-UP
DISPOSITION
Discharge Criteria
  • Patients with fibrocystic changes are appropriate for discharge with outpatient follow-up
  • Encourage patient to keep a breast pain record to determine whether pain is cyclic
  • The importance of follow-up should be stressed to ensure patient health, disease prevention, and patient satisfaction
  • Encourage regular breast self-exam, annual physical exams, and annual mammograms when appropriate
Issues for Referral
  • Practically speaking, all breast masses evaluated in the ED need referral to a primary provider or specialized breast clinic
  • Further investigation with imaging and possible biopsy are required for masses that persist throughout menses and are not cyclical
  • Referral to a general surgeon may be required in certain cases where tissue biopsy is necessary
PEARLS AND PITFALLS
  • Breast cancer may coexist with benign breast disease and fibrocystic changes:
    • Consider all cancer risk factors
    • Confirm follow-up plan
  • Mastitis in a nonlactating patient should be treated as inflammatory carcinoma until proven otherwise
  • Fibrocystic changes are usually bilateral; unilateral changes are suspicious for cancer
  • Fear of breast cancer is high in all patients:
    • Give reassurance that fibrocystic breast changes are not cancerous
    • Have a low threshold for referral to a specialist
ADDITIONAL READING
  • Grube BJ, Giuliano AE. Benign breast disease. In: Berek JS, ed.
    Berek & Novak’s Gynecology
    . 14th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:652–654.
  • Institute for Clinical Systems Improvement (ICSI).
    Diagnosis of Breast Disease
    . Bloomington, MN: Institute for Clinical Systems Improvement; 2005.
  • Katz VL, Dotter D. Breast diseases: Diagnosis and treatment of benign and malignant disease. In: Lentz GM, Lobo RA, Gershenson DM, et al., eds.
    Comprehensive Gynecology.
    6th ed. Philadelphia, PA: Elsevier; 2012:304–306.
  • Marchant DJ. Benign breastdisease.
    Obstet Gynecol Clin North Am.
    2002;29:1–20.
  • Parikh JR. ACR appropriateness criteria on palpable breast masses.
    J Am Coll Radiol.
    2007;4:285–288.
  • Parikh JR, EvansWP, Bassett L, et al.Expert Panel on Women’s Imaging—Breast. Palpable Breast Masses. Reston, VA: American College of Radiology (ACR);2006.
  • Rastelli A. Breast pain, fibrocystic changes, and breast cysts.
    Probl Gen Surg.
    2003;20:17–26.
  • Santen RJ, Mansel R. Benign breast disorders.
    N Engl J Med.
    2005;353:275–285.

Other books

Maxwell Street Blues by Marc Krulewitch
Kitten Catastrophe by Anna Wilson
The Automatic Detective by A. Lee Martinez
The Baker’s Daughter by D. E. Stevenson
Sweet Mystery by Emery, Lynn
Serena's Submission by Jasmine Hill